• Impact of Daratumumab

    20 September 2017 01:30pm - 02:00pm - Australia/Sydney

    Investigate the challenges faced by a transfusion laboratory as they perform pre-transfusion testing to find compatible blood for multiple myeloma patients undergoing Daratumumab therapy and how these issues can be resolved.

    Learning outcomes:

    • Describe the impacts of Daratumumab on pre-transfusion testing and investigation processes.
    • Improve awareness of the key challenges faced by a transfusion laboratory when providing compatible blood for multiple myeloma patients


    		Presenters: Ms Kerman Buhariwala, Medical Scientist, Clinical Services and Research, Blood Service.
    • Permission has not been granted to publish the recording of this presentation.

  • Thank you for attending this event. Please complete the feedback form below to access your certificate.